Patents by Inventor Andrew Humberstone

Andrew Humberstone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160250227
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: October 6, 2015
    Publication date: September 1, 2016
    Applicant: Acrux DDS Pty Ltd
    Inventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
  • Patent number: 9180194
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: November 10, 2015
    Assignee: ACRUX DDS PTY LTD
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
  • Patent number: 8993520
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: March 31, 2015
    Assignee: Acrux DDS Pty Ltd
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
  • Publication number: 20150087623
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: October 8, 2014
    Publication date: March 26, 2015
    Applicant: Acrux DDS Pty Ltd
    Inventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
  • Patent number: 8435944
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: May 7, 2013
    Assignee: Acrux DDS Pty Ltd.
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
  • Publication number: 20100322884
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: June 25, 2010
    Publication date: December 23, 2010
    Inventors: Tony DiPietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Monique Robinson, Kerrie Setiawan, Carolyn Stone, Nina Wilkins
  • Publication number: 20070255197
    Abstract: This invention relates to a method for inhibiting the percutaneous absorption of a physiologically active agent topically applied to a transdermal administration site of a subject, the method including the step of applying to skin of the subject at the transdermal administration site, a device (1, 7) comprising a membrane (8) for contacting the skin of the subject coated on the skin contacting side thereof (11) with a layer of an adhesive (10).
    Type: Application
    Filed: December 9, 2004
    Publication date: November 1, 2007
    Inventors: Andrew Humberstone, Nina Wilkins, Igor Gonda
  • Publication number: 20060280783
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: June 2, 2006
    Publication date: December 14, 2006
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Monique Robinson, Kerrie Setiawan, Carolyn Stone, Nina Wilkins
  • Publication number: 20050002868
    Abstract: A method of treatment of a female suffering from androgen insufficiency comprising administering to at least one of the abdomen and forearm of the female a transdermal spray or aerosol comprising an androgen.
    Type: Application
    Filed: June 18, 2004
    Publication date: January 6, 2005
    Inventors: Igor Gonda, Nina Wilkins, Andrew Humberstone